Finance

Lists
RMD:NYSE
Resmed Inc
US$220,69
-0,97%
(-2,17) 1D
US$221,23
+0,24% (+0,54)
After hours
Closed: 6 ຕ.ລ., 16 ໂມງ 0 ນາທີ 03 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
US$223,90
High
US$225,23
Low
US$219,96
Mkt. cap
30,48 ຕື້
Avg. vol.
1,28 ລ້ານ
Volume
972,85 ພັນ
Dividend
1,20%
Quarterly dividend
US$0,66
Ex-dividend date
20 ສ.ຫ. 2026
P/E ratio
21,16
52-wk high
US$284,87
52-wk low
US$180,26
EPS
US$10,43
Beta
0,75
Shares outstanding
140,64 ລ້ານ
No. of employees
11 ພັນ
Open
US$223,90
High
US$225,23
Low
US$219,96
Mkt. cap
30,48 ຕື້
Avg. vol.
1,28 ລ້ານ
Volume
972,85 ພັນ
Dividend
1,20%
Quarterly dividend
US$0,66
Ex-dividend date
20 ສ.ຫ. 2026
P/E ratio
21,16
52-wk high
US$284,87
52-wk low
US$180,26
EPS
US$10,43
Beta
0,75
Shares outstanding
140,64 ລ້ານ
No. of employees
11 ພັນ
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
21 ຊົ່ວໂມງກ່ອນ
ResMed stock pre-market at EUR 199.20: plus 0.48 percent
TradingView
TradingView
·
1 ມື້ກ່ອນ
ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc
CEOMichael J. Farrell
Employees11,4 ພັນ
Foundedມິ.ຖ. 1989
Headquartersແຊນ ດີເອໂກ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorMedical device
Websiteresmed.com
Analyst ratings
Based on 15 analysts giving stock ratings to RMD in the past 3 months
Buy
Buy
5
Hold
10
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for RMD in the last 3 months.
Highest
Current US$220,69
US$320,00 (+45,00%)
Average
US$241,42 (+9,39%)
Lowest
US$213,00 (-3,48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Block
Stifel Nicolaus
Hold
Maintained
US$235,00
+6,5%
10/02/2026
Craig Wong-Pan
RBC Capital
Buy
Upgraded
US$262,00
+18,7%
09/15/2026
Laura Sutcliffe
Citi
Hold
Maintained
US$240,00
+8,7%
09/10/2026
Brett Fishbin
KeyBanc
Buy
Reiterated
US$267,00
+21%
08/31/2026
Jackson Philips
Rothschild & Co Redburn
Hold
Initiated
US$230,00
+4,2%
08/19/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
US$235,00
+6,5%
08/11/2026
Unknown Analyst
Oppenheimer
Hold
Reiterated
-
-
08/07/2026
Adam Maeder
Piper Sandler
Hold
Maintained
US$225,00
+2%
08/07/2026
David Rescott
Robert W. Baird
Hold
Maintained
US$213,00
-3,5%
08/07/2026
Nathan Treybeck
Wells Fargo
Hold
Reiterated
US$215,00
-2,6%
08/07/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/07/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/07/2026
Lyanne Harrison
Bank of America Securities
Buy
Maintained
US$320,00
+45%
07/29/2026
David Bailey
Morgan Stanley
Hold
Maintained
US$230,00
+4,2%
07/13/2026
Matthew Taylor
Jefferies
Hold
Maintained
US$225,00
+2%
07/10/2026
Unknown Analyst
Jefferies
Hold
Reiterated
US$225,00
+2%
07/10/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
US$227,00
+2,9%
05/01/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
-
-
04/15/2026
Chris Cooper
J.P. Morgan
Buy
Initiated
-
-
04/15/2026
Unknown Analyst
Evercore ISI
Buy
Maintained
US$255,00
+15,5%
04/13/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
US$270,00
+22,3%
01/30/2026
Mark Wilson CFA
RBC Capital
Buy
Maintained
US$314,00
+42,3%
01/30/2026
Last report
6 ສ.ຫ. 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
US$0,30 / US$2,89
-89,80%miss
Revenue / Est. (USD)
1,46 ຕື້ / 1,46 ຕື້
+0,21%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
1,34 ຕື້
1,42 ຕື້
1,43 ຕື້
1,46 ຕື້
Cost of goods sold
506,94 ລ້ານ
536,28 ລ້ານ
532,58 ລ້ານ
594,13 ລ້ານ
Cost of revenue
506,94 ລ້ານ
536,28 ລ້ານ
532,58 ລ້ານ
594,13 ລ້ານ
Research and development expenses
87,32 ລ້ານ
90,97 ລ້ານ
94,27 ລ້ານ
105,72 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259,19 ລ້ານ
275,70 ລ້ານ
279,80 ລ້ານ
293,36 ລ້ານ
Operating expense
366,29 ລ້ານ
386,24 ລ້ານ
393,16 ລ້ານ
417,88 ລ້ານ
Total operating expenses
873,24 ລ້ານ
922,51 ລ້ານ
925,74 ລ້ານ
1,01 ຕື້
Operating income
462,35 ລ້ານ
500,30 ລ້ານ
505,67 ລ້ານ
451,64 ລ້ານ
Other non operating income
-3,84 ລ້ານ
42,00 ພັນ
181,00 ພັນ
4,40 ລ້ານ
EBT including unusual items
446,79 ລ້ານ
496,15 ລ້ານ
502,31 ລ້ານ
474,16 ລ້ານ
EBT excluding unusual items
468,79 ລ້ານ
504,48 ລ້ານ
518,30 ລ້ານ
476,09 ລ້ານ
Income tax expense
98,26 ລ້ານ
103,56 ລ້ານ
103,58 ລ້ານ
90,73 ລ້ານ
Effective tax rate
21,99%
20,87%
20,62%
19,14%
Other operating expenses
-
-
-
-
Net income
348,54 ລ້ານ
392,59 ລ້ານ
398,73 ລ້ານ
383,43 ລ້ານ
Net profit margin
26,10%
27,59%
27,86%
26,20%
Earnings per share
2,55
2,81
0,29
0,30
Interest and investment income
4,69 ລ້ານ
4,46 ລ້ານ
3,80 ລ້ານ
31,76 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
4,69 ລ້ານ
4,46 ລ້ານ
3,80 ລ້ານ
31,76 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
503,64 ລ້ານ
543,79 ລ້ານ
558,22 ລ້ານ
490,13 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google